@article{d4513503f7d54e8cade11ca9a6960ba6,
title = "Standards of evidence for conducting and reporting economic evaluations in prevention science",
abstract = "Over a decade ago, the Society for Prevention Research endorsed the first standards of evidence for research in preventive interventions. The growing recognition of the need to use limited resources to make sound investments in prevention led the Board of Directors to charge a new task force to set standards for research in analysis of the economic impact of preventive interventions. This article reports the findings of this group{\textquoteright}s deliberations, proposes standards for economic analyses, and identifies opportunities for future prevention science. Through examples, policymakers{\textquoteright} need and use of economic analysis are described. Standards are proposed for framing economic analysis, estimating costs of prevention programs, estimating benefits of prevention programs, implementing summary metrics, handling uncertainty in estimates, and reporting findings. Topics for research in economic analysis are identified. The SPR Board of Directors endorses the “Standards of Evidence for Conducting and Reporting Economic Evaluations in Prevention Science.”",
author = "Crowley, {D. Max} and Dodge, {Kenneth A.} and Barnett, {W. Steven} and Phaedra Corso and Sarah Duffy and Phillip Graham and Mark Greenberg and Ron Haskins and Laura Hill and Jones, {Damon E.} and Karoly, {Lynn A.} and Kuklinski, {Margaret R.} and Robert Plotnick",
note = "Funding Information: Mapping Advances in Prevention Science (MAPS) are multidisciplinary task forces commissioned by the Society for Prevention Research and funded by the National Institute on Drug Abuse. They are designed to address prevention research and practice in areas deemed especially important to advancing the state of the field. The MAPS I task force focused on the role of biological factors in prevention research, and MAPS II focused on type 2 translational research. The current MAPS III focuses on the economic costs and benefits of preventive interventions and policies. The charge of the MAPS III task force was to (1) provide guidance regarding current standards and best practices in the economic evaluation of preventive interventions and policies, (2) recommend actions to increase the field{\textquoteright}s capacity to conduct and report high-quality economic evaluations, and (3) identify research gaps and policy needs specific to economic evaluation of prevention. This report summarizes the findings and recommendations of the MAPS III Task Force. Funding Information: Funding Information This work was supported by the Society for Prevention Research and is a product of the Mapping Advances in Prevention Science (MAPS) Initiative. Research reported in this publication was also supported by the National Institute on Drug Abuse of the National Institutes of Health under Award Number R13DA033149. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Publisher Copyright: {\textcopyright} The Author(s) 2018.",
year = "2018",
month = apr,
doi = "10.1007/s11121-017-0858-1",
language = "English (US)",
volume = "19",
pages = "366--390",
journal = "Prevention Science",
issn = "1389-4986",
publisher = "Springer New York",
number = "3",
}